Medical Cannabis Europe Conference returns to Lisbon on 15 and 16 September

The partnership between Stepwise Pharma & Engineering and the LEF - Laboratory of Pharmaceutical Studies, reorganizes the Medical Cannabis Europe, an international conference that takes place on the 15th and 16th of September at the Auditorium of the National Association of Pharmacies (ANF), in Lisbon. At inscriptions are already open on the event's official website and cost €525 (+VAT, one day) or €795 (+VAT, both days) with a discount for groups. Students can access the conference for just €25 (+VAT).

With studies and clinical trials revealing the great therapeutic potential of medical cannabis, the industry is alert to the business opportunity in a market that, according to several analysts, could reach 3,2 billion euros by 2025, with the legalization of the sale. of these products in several European countries.

Medical Cannabis Europe aims to create reflection among those interested in the field of medical cannabis, fostering dialogue, current knowledge and good practices, as well as allowing scrutiny on the introduction, with quality and safety, of medicinal cannabis products in the national and international market.

It is in this context, and after the success of the first edition held in 2020, that Lisbon hosts another event of international expression, where around 150 participants and entities involved in the medical cannabis industry are expected, from investors and manufacturers to suppliers, importers and exporters, through distributors, industry professionals and inspectors.

O SCHEDULE has national and international speakers and specialists, who will reveal the news of the European and Portuguese market, evaluate the practice, regulation and structures of other markets such as Spanish, Israeli and Swiss, and share contributions to the cultivation, production and extraction of medical cannabis.

In the two days of the event, the challenges of the medical cannabis industry will be analyzed, namely compliance with regulations for placing on the market of cannabis plant-based products for medicinal purposes that demonstrate consistency, quality, efficacy and safety. According to the organization, “these are prerequisites for the trust of authorities and patients in medical cannabis that will contribute to its development, also in Portugal”.

According to Medical Cannabis Europe, “the conference will be represented by health-related structures, such as representatives of the government, Infarmed, the Portuguese Environment Agency, the Order of Doctors and Pharmacists, among others, as well as associations dedicated to the well-being of patients”. ”, in addition to companies such as Cleaver Leaves, Azierta, Cannavigia, Ionisos Ibérica, Tilray, Medicane, MuvuTechnologies, Cannaflos, Agrify or Rotronic, among others.

More information can be obtained via email info@medicalcannabiseurope.pt